Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact the trial administrator to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- Keck Hospital of USC, Los Angeles, California, 90033
- LAC + USC Medical Center, Los Angeles, California, 90033
- USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033
- University of California San Diego / Moores Cancer Center, La Jolla, California, 91914
-
Washington
- Seattle Cancer Care Alliance, Seattle, Washington, 98109
-
Texas
- Urology San Antonio Research, San Antonio, Texas, 78229
-
Alabama
- Urology Center of Alabama, Homewood, Alabama, 35209
Powered by
SC CTSI